chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Total Blowout flu; Bedridden for three days; Sick; Serious diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Total Blowout flu), IMMUNISATION REACTION (Bedridden for three days), ILLNESS (Sick), DIARRHOEA (Serious diarrhea) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Total Blowout flu), IMMUNISATION REACTION (Bedridden for three days), ILLNESS (Sick), DIARRHOEA (Serious diarrhea) and CHILLS (Chills). At the time of the report, INFLUENZA (Total Blowout flu), IMMUNISATION REACTION (Bedridden for three days), ILLNESS (Sick), DIARRHOEA (Serious diarrhea) and CHILLS (Chills) outcome was unknown.            No concomitant medication information was provided.  It was reported that after vaccination, as week later the side effects were horrendous. It was reported that the patient did not like Pfizer, patient preferred Moderna.  No treatment information was provided.
Patient with 10-15 minutes episode of unconsciousness, limpness and incontinence described.  Patient taken to emergency department locally by emergency medical services and found to have fever to 102.8.  Patient with positive post ictal confusion, resolved completely.  Diagnosed with febrile seizure, no source of fever identified.
Sudden low grade fever (100.2-100.4); Bodyache; GI distress; Frequent loose BM; Nausea; Fatigue; HA; This is a spontaneous report from a contactable nurse, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 22Feb2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. Concomitant medications included alendronate (MANUFACTURER UNKNOWN) for unknown indication and from unknown date. The patient previously took epinephrine for unknown indication and on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 01Feb2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had been tested for COVID-19.  On 28Mar2021 at 12:00, 36 days after receiving the second dose, the patient experienced sudden low-grade fever (100.2-100.4), body ache, HA(adverse event Nos), GI(Gastro intestinal) distress with nausea, frequent loose BM(bowel movements) and fatigue that lasted for 48 hrs. Symptoms resolved by 3rd day. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. On 30Mar2021, the patient underwent rapid molecular PCR COVID test (Nasal swab) and the result was negative. The clinical outcome of the events slight fever, general body pain, adverse event Nos, distress gastrointestinal, nausea, loose bowel movements and fatigue was resolved on an unknown date.  No follow-up attempts are needed. No further information is expected.
difficult to move/difficult to walk; sweating, wrenched in sweat; low grade fever; body aches; chills, could not get warm, bone chills; headache, hit like a ton of bricks; every joint hurt; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (difficult to move/difficult to walk), HYPERHIDROSIS (sweating, wrenched in sweat), PYREXIA (low grade fever), MYALGIA (body aches) and CHILLS (chills, could not get warm, bone chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21 and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood transfusion (blood transfusion as an infant.) and Lumpectomy (breast cancer) (breast lumpectomy.). Concurrent medical conditions included Immunocompromised (complications her whole life for being immunocompromised), Obesity (Over weight), Smoker (Smoker) and Dermatitis (skin issues (dermatitis)).   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (difficult to move/difficult to walk), HYPERHIDROSIS (sweating, wrenched in sweat), PYREXIA (low grade fever), MYALGIA (body aches), CHILLS (chills, could not get warm, bone chills), HEADACHE (headache, hit like a ton of bricks), ARTHRALGIA (every joint hurt) and VACCINATION SITE PAIN (sore arm). At the time of the report, MOBILITY DECREASED (difficult to move/difficult to walk), HYPERHIDROSIS (sweating, wrenched in sweat), PYREXIA (low grade fever), MYALGIA (body aches), CHILLS (chills, could not get warm, bone chills), HEADACHE (headache, hit like a ton of bricks), ARTHRALGIA (every joint hurt) and VACCINATION SITE PAIN (sore arm) outcome was unknown.            Cholesterol pills, fish oil supplement, she gets once or twice a year a shot for osteoporosis, ointments for dermatitis issues- were used as concomitant medications.  No treatment medication was provided.   This case was linked to MOD-2021-377795, MOD-2021-377778, MOD-2021-377785 (Patient Link).
fever >100 , body aches/whole body muscle spasms, chills, nausea (no vomiting), headaches, physical exhaustion, all symptoms resolved approx 1.5 days of vaccine administered, symptoms began approx 12 after vaccine received.
I received my vaccine at 10:15 am on March 18, 2021, and was fine until 6 pm that evening.After eating dinner, I took my omesartan and pravastatin, as usual, and within 10 minutes, my heart rate became erratic.  I have tachycardia (SVT) but control it with atenolol.  I went to the ER at where I had an EKG, ches xray, and blood work.  My heartbeat reached 143.  While waiting on the test results, I noticed a rash forming below both my knees.  The ER doctor returned with the news that all tests came back normal with no accounting for the rapid heart beat other than the Pfizer vaccine.  He checked the rash saying it was likely another reaction from the vaccine.  He gave me medication to reduce my heart rate, prescribed hydrocortisone for the "rash" and released me.  By the next morning, my heart rate was back to normal but the "rash" had spread all over both legs.  On Saturday, March 20,, 2021, I went to a medical clinic to see if I could Triamcinolone Acetonide on the rash as the hydrocortisone wasn't helping.  The NP identified the rash as petechiae and prescribed Triamcinolone.  She could not prescribe an oral steroid xplaining that not enough info is known about the Covid vaccines and possible interactions with steroids.  I then followed up on Monday, March 22, 2021, with my PCP who said I had a bad case of petechiae and did more blood work to rule out vasculitis.  The day before getting the vaccine, I competed a 7-day course of the antibiotic Nitrofurintoin for a UTI and suggested to her that perhaps I  had a delayed reaction to it.  However, she ruled that out saying I would likely have had a reaction before the day after completing the medication.  She called me back the next evening on Tuesday, March 23 advising that all blood work came back negative, that the Pfizer vaccine is  likely the cause of the petechiae, and that I should probably not get the 2nd vaccine.  I asked her if she thought I would be okay getting the Johnson & Johnson vaccine and she said yes, if they will give it to you.  I could not get directed to anyone to answer that question,  but I need to know.  Can you help  me?
The pt was very pale with very little movement 3 hours post vax. This lasted approximately 30 minutes and by the time the pt was seen, the exam was within normal limits.
fever; chills; body aches; headaches; This case was reported by a consumer via call center representative and described the occurrence of fever in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In December 2019, the patient received the 1st dose of Shingrix (intramuscular). In December 2019, less than a day after receiving Shingrix, the patient experienced fever, chills, general body pain and headache. On an unknown date, the outcome of the fever, chills, general body pain and headache were recovered/resolved.   It was unknown if the reporter considered the fever, chills, general body pain and headache to be related to Shingrix.  Additional details were provided as follows: Caller was a patient. The patient received the 1st dose of Shingrix during the last week of December 2019. Patient states that on the same evening that she received the vaccine, she developed fever, chills, body aches and headaches. Patient states that these symptoms lasted for approximately 3 days before resolving. Consented to follow up.
Initial unsolicited report received from a consumer who was also a physician on 6 October 2015. This case involves a 66-year-old female patient who was vaccinated with a dose of FLUZONE HD (batch number, route and site of administration not reported) on an unspecified date. The patient's pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was reported as NKA(no known allergy), none, Illness at time of vaccination was none and concomitant medications were reported as none. On 6 October 2015, about 2 weeks after the vaccination the patient had experienced large hematoma at the site with pain and itching without rash. The patient also reported that the hematoma was 7 inches by 6 inches approximately The patient required ER/doctor visit. Laboratory investigations includes platelet count and corrective treatments were not reported. The final outcome for the events was reported as not recovered. Documents held by sender: none
patient complained of itching at injection site and lower right leg, caregiver came back to the pharmacy, waited 45 minutes additionally , patient was given water, possibly anxiety
Mild cough which got worse over the course of the day; Feeling a little sick; Sore throat; General soreness; Temperature was 102.1; Headache; General fatigue; This spontaneous case was received on 12-Nov-2022, from other non-healthcare professional (consumer) via Communications (reference number: SEQW22-05741) and concerned a 42-year-old male patient.   The patient's medical history and concomitant medications were not reported. The patient's historical vaccines included two Flucelvax Quadrivalent (influenza vaccine inact sag 4v), both administered on an unspecified date, over the past two years.   On 06-Oct-2022, at approximately 9am, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose, route of administration, anatomical location and indication: not reported). The batch number was not reported.   On 11-Nov-2022, one month and five days after receiving Flucelvax Quadrivalent, the patient started feeling a little sick. The patient woke up with very mild cough which got worse over the course of the day. The symptoms persisted overnight.  On an unspecified date in Nov-2022 (between 11-Nov-2022 and 12-Nov-2022), an unknown amount of time after receiving Flucelvax Quadrivalent, the patient experienced cough, mild sore throat, headache, general fatigue/soreness, and his temperature was 102.1.  On unspecified date in Nov-2022, the patient took two COVID-19 tests, and the results were negative. At the time of the initial reporting, the patient did not have any plans to go to the doctor or be tested for any other respiratory viruses.  At the time of the initial reporting, the patient had not recovered from the events.  The reporter did not provide a causality assessment. It was in the patient's opinion that these were possible adverse events, but he was not 100 percent sure if they were reportable.  The case was assessed as non-serious.  Company comment: A 42-year-old male patient was vaccinated with Flucelvax Quadrivalent. Approximately one month following vaccination, patient reported cough, oropharyngeal pain, pain, body temperature increased, headache, fatigue and malaise. Due to unsuggestive temporal relationship, reported events are assessed as not related to the suspect product.; Sender's Comments: A 42-year-old male patient was vaccinated with Flucelvax Quadrivalent. Approximately one month following vaccination, patient reported cough, oropharyngeal pain, pain, body temperature increased, headache, fatigue and malaise. Due to unsuggestive temporal relationship, reported events are assessed as not related to the suspect product.
arm is red; arm was hot; "but itches like a bug bite."; hardness at the injection site; area has some dots and looks rashy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm was hot), VACCINATION SITE PRURITUS ("but itches like a bug bite.") and VACCINATION SITE INDURATION (hardness at the injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm was hot), VACCINATION SITE PRURITUS ("but itches like a bug bite."), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE RASH (area has some dots and looks rashy). On 12-Jan-2021, VACCINATION SITE PAIN (sore arm) had not resolved. At the time of the report, VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm was hot), VACCINATION SITE PRURITUS ("but itches like a bug bite."), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE RASH (area has some dots and looks rashy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Left arm with large local reaction (redness, heat, tenderness). No fevers, myalgia or shortness of breath.
1 1/2-2" diameter red and warm to touch. Mother denies fever or other symptoms. Apply warm compresses.
Patient reports swelling and pain at site beginning 2 days after vaccine and still going on without relief.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received Shingrix for prophylaxis. On 18th September 2018, the patient received the 1st dose of Shingrix. In September 2018, less than a week after receiving Shingrix, the patient experienced headache, upset stomach, injection site pain, fever, injection site swelling, muscle pain, tiredness, shivering and injection site erythema. On an unknown date, the outcome of the headache, upset stomach, injection site pain, fever, injection site swelling, muscle pain, tiredness, shivering and injection site erythema were unknown. It was unknown if the reporter considered the headache, upset stomach, injection site pain, fever, injection site swelling, muscle pain, tiredness, shivering and injection site erythema to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient called after hours and left a voicemail to report an adverse event. The patient was experiencing headache, shivering, upset stomach, muscle pain, tiredness and fever. The patient also states that she is experiencing pain, redness and swelling at the injection site. The patient did not provide any additional details on the voicemail.
Information has been received from a pharmacist concerning a patient, who on 05-SEP-2012 was inadvertently vaccinated with a dose of VARIVAX (Merck), 0.65ml, subcutaneously, instead of ZOSTAVAX due to a staff error. No adverse effect was reported. Additional information has been requested.
Regarding   Health on the following COVID Vaccine Moderna. Please see the following determination; Doses Administered from 4.6.2021 to 5.21.2021:Based on the information you have provided and the lack of temperature data, we are not able to conduct an analysis or guarantee the doses administered between 4/6/2021 and 5/21/2021 provided the necessary protection against a COVID-19 infection. Please continue with the original plan of action on revaccination and completing a VAERS Reports on the all clients you have identified.
On 29Aug2019 / received the first /dose / did not return within the recommended time frame to receive the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of Shingrix on 29th August 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not return within the recommended time frame to receive second dose of Shingrix which led to incomplete course of vaccination. The reporter consented to follow up.
4 days post vax, the pt experienced a rash, blisters, bumps, sores, red hands and feet. No fever, but rash slightly itchy.
Pt complained of joint pain in shoulders and hands; constipation; painful bloating; acne; weight gain. Anthrax #1 given 1/25/91; Anthrax #2 given 2/15/91 and gained 20 pounds over a few months. In 1993, she began having panic attacks and was dx'd with anxiety, adjustment and panic disorder; symptoms managed with therapy and stress management. In 1994, she had onset of constipation and short term memory loss. She did not have time to seek treatment at this point. Anthrax #3 given on 9/10/98; Anthrax #4 given 9/24/98 and had flu-like symptoms starting 3 days, post vax, with fatigue, muscle aches, excessive sleepiness and felt as though she were in a daze. She also experienced an unusual amount of crying. All symptoms lasted a week. Anthrax #5 given 10/8/98 and had same flu-like, fatigue, crying and withdrawal from family symptoms as with shot #4. Started 3 days, post vax, and lasted 2 weeks. During 6 month interval between shots #5 and #6, she had GI problems of constipation, bloating, lower abdominal pain and white mucous around stools increased. Anthrax #6 given 3/9/99; Anthrax #7 on 9/8/99 and tolerated both of these well. In 1/00, she began experiencing severe joint pain in her shoulders and left knee. Numbness radiates from the shoulders to the fingers. Anthrax #8 given on 3/6/00 and tolerated well. Symptoms that began after 7th Anthrax also included pain to the touch on the back of her neck and the medial aspects of both feet. She was dx'd with bursitis/arthritis, AC joint arthritis and impingement. She has tried both Celebrex and high dose Motrin with no relief. An orthopedic physician is currently managing her care. She began receiving cortisone shots every 6-8 weeks in 8/01. In 9/01, surgery was performed on her right shoulder and she received physical therapy from 10/01 to 1/02 and given a TENS machine for pain management (which she still uses daily). She was dx'd irritable bowel syndrome and prescribed a high fiber diet for the constipation. In 4/01 she began taking Paxil 20mg every day, which in conjunction with coping and stress management skills, is controlling her anxiety. She has not had a panic attack since 1993. Since 1991, she has been experiencing constant, painful acne on her face, lower legs and on the skin between her breasts. She has been on minocycline since 1991. Plan to refer to Rheumatology for joint pain, Dermatology for acne and refer to GI on symptoms of constipation.
Patient's parent consented to patient being 12 years old, but patient was actually born later and was not actually old enough to receive vaccine. Patient's parent reported that the insurance company had the wrong date of birth, so the pharmacist-on-duty agreed to vaccinate the patient and bill the claim for the vaccine later. Patient returned to the pharmacy on Sunday, 10/17/21 to receive her 2nd dose and the insurance issue had not been resolved. At this time, the pharmacist-on-duty consulted the Registry Information System and noted that the date of birth was listed as the patient being 11. The pharmacist refused to administer the 2nd Pfizer vaccine at that time. The pharmacist then called the Dept of Public Health on Tues, 10/19 and reported the incident.
I had no side effects up until 3 days later, 02/25/2021, during lunch my heart started racing and pounding and I could not catch my breath. I tried to relax and eat and I felt like I had indigestion coming on. Then I started feeling very mild tightness in my throat. Later I had mild ringing in my ears. i had intense anxiety from the time my heart started pounding. ALL of these symptoms lasted for 3 days and It only happened when I ate food. I tossed and turned all night and my body was very uncomfortable and I was still extremely anxious. I started getting better after 3 days and took about 9 days to finally start feeling right. Doctor gave me an EKG and said it was fine but sent me to a cardiologist. I had another EKG, ECHO,  24 hour Monitor with a Holter, and a stress test. results pending. PLEASE NOTE: I am allergic to Cipro and I found that there is a common ingredient in Cipro and the Covid vaccines: Polyethylene Glycol Maybe there's a correlation?
Information has been received from a physician concerning a 50 year old female who was vaccinated with MMR II prior to medical school. Subsequently the pt experienced arthralgias and myalgia. Unspecified medical attention was sought. Additional info has been requested.
The adverse events I experienced were tachycardia, chest pain, shortness of breath, and dizziness that began after I got the vaccine.  I also experienced pain where I got the vaccine, fatigue, and nausea.
Fever of 100-101. Body aches and chills. Headache. Lasted 10 hours.